vs
PTC Inc.（PTC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
PTC Inc.的季度营收约是Royalty Pharma plc的1.1倍（$685.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 24.3%，领先10.2%），PTC Inc.同比增速更快（21.4% vs 4.8%），过去两年PTC Inc.的营收复合增速更高（6.6% vs 4.6%）
PTC是1985年成立的美国计算机软件与服务企业，总部位于马萨诸塞州波士顿。公司1988年率先推出参数化关联特征驱动的三维CAD建模软件，1998年发布基于互联网的产品生命周期管理（PLM）产品，目前面向合作伙伴与开发者提供物联网、增强现实（AR）平台及相关产品服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PTC vs RPRX — 直观对比
营收规模更大
PTC
是对方的1.1倍
$622.0M
营收增速更快
PTC
高出16.6%
4.8%
净利率更高
RPRX
高出10.2%
24.3%
两年增速更快
PTC
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $685.8M | $622.0M |
| 净利润 | $166.5M | $214.2M |
| 毛利率 | 82.8% | — |
| 营业利润率 | 32.2% | 62.4% |
| 净利率 | 24.3% | 34.4% |
| 营收同比 | 21.4% | 4.8% |
| 净利润同比 | 102.5% | 2.9% |
| 每股收益（稀释后） | $1.39 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTCRPRX
| Q4 25 | $685.8M | $622.0M | ||
| Q3 25 | $893.8M | $609.3M | ||
| Q2 25 | $643.9M | $578.7M | ||
| Q1 25 | $636.4M | $568.2M | ||
| Q4 24 | $565.1M | $593.6M | ||
| Q3 24 | $626.5M | $564.7M | ||
| Q2 24 | $518.6M | $537.3M | ||
| Q1 24 | $603.1M | $568.0M |
净利润PTCRPRX
| Q4 25 | $166.5M | $214.2M | ||
| Q3 25 | $347.8M | $288.2M | ||
| Q2 25 | $141.3M | $30.2M | ||
| Q1 25 | $162.6M | $238.3M | ||
| Q4 24 | $82.2M | $208.2M | ||
| Q3 24 | $126.5M | $544.0M | ||
| Q2 24 | $69.0M | $102.0M | ||
| Q1 24 | $114.4M | $4.8M |
毛利率PTCRPRX
| Q4 25 | 82.8% | — | ||
| Q3 25 | 86.9% | — | ||
| Q2 25 | 82.9% | — | ||
| Q1 25 | 83.3% | — | ||
| Q4 24 | 80.2% | — | ||
| Q3 24 | 82.0% | — | ||
| Q2 24 | 78.4% | — | ||
| Q1 24 | 81.8% | — |
营业利润率PTCRPRX
| Q4 25 | 32.2% | 62.4% | ||
| Q3 25 | 48.5% | 70.1% | ||
| Q2 25 | 32.6% | 36.3% | ||
| Q1 25 | 35.1% | 94.0% | ||
| Q4 24 | 20.4% | 60.9% | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 18.5% | 50.2% | ||
| Q1 24 | 29.8% | -13.0% |
净利率PTCRPRX
| Q4 25 | 24.3% | 34.4% | ||
| Q3 25 | 38.9% | 47.3% | ||
| Q2 25 | 21.9% | 5.2% | ||
| Q1 25 | 25.6% | 41.9% | ||
| Q4 24 | 14.6% | 35.1% | ||
| Q3 24 | 20.2% | 96.3% | ||
| Q2 24 | 13.3% | 19.0% | ||
| Q1 24 | 19.0% | 0.8% |
每股收益（稀释后）PTCRPRX
| Q4 25 | $1.39 | $0.49 | ||
| Q3 25 | $2.88 | $0.67 | ||
| Q2 25 | $1.17 | $0.07 | ||
| Q1 25 | $1.35 | $0.55 | ||
| Q4 24 | $0.68 | $0.46 | ||
| Q3 24 | $1.05 | $1.21 | ||
| Q2 24 | $0.57 | $0.23 | ||
| Q1 24 | $0.95 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $209.7M | $618.7M |
| 总债务越低越好 | $1.2B | $9.0B |
| 股东权益账面价值 | $3.8B | $9.7B |
| 总资产 | $6.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.31× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PTCRPRX
| Q4 25 | $209.7M | $618.7M | ||
| Q3 25 | $184.4M | $938.9M | ||
| Q2 25 | $199.3M | $631.9M | ||
| Q1 25 | $235.2M | $1.1B | ||
| Q4 24 | $196.3M | $929.0M | ||
| Q3 24 | $265.8M | $950.1M | ||
| Q2 24 | $247.7M | $1.8B | ||
| Q1 24 | $249.0M | $843.0M |
总债务PTCRPRX
| Q4 25 | $1.2B | $9.0B | ||
| Q3 25 | $1.2B | $8.9B | ||
| Q2 25 | $1.2B | $8.0B | ||
| Q1 25 | $1.4B | $7.6B | ||
| Q4 24 | $1.0B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.3B | $7.6B | ||
| Q1 24 | $1.5B | $6.1B |
股东权益PTCRPRX
| Q4 25 | $3.8B | $9.7B | ||
| Q3 25 | $3.8B | $9.6B | ||
| Q2 25 | $3.5B | $9.5B | ||
| Q1 25 | $3.4B | $9.8B | ||
| Q4 24 | $3.2B | $10.3B | ||
| Q3 24 | $3.2B | $10.3B | ||
| Q2 24 | $3.0B | $9.8B | ||
| Q1 24 | $2.9B | $9.9B |
总资产PTCRPRX
| Q4 25 | $6.4B | $19.6B | ||
| Q3 25 | $6.6B | $19.3B | ||
| Q2 25 | $6.2B | $18.3B | ||
| Q1 25 | $6.2B | $17.6B | ||
| Q4 24 | $6.1B | $18.2B | ||
| Q3 24 | $6.4B | $18.0B | ||
| Q2 24 | $6.1B | $17.7B | ||
| Q1 24 | $6.2B | $16.1B |
负债/权益比PTCRPRX
| Q4 25 | 0.31× | 0.92× | ||
| Q3 25 | 0.31× | 0.93× | ||
| Q2 25 | 0.34× | 0.84× | ||
| Q1 25 | 0.40× | 0.78× | ||
| Q4 24 | 0.32× | 0.74× | ||
| Q3 24 | 0.38× | 0.74× | ||
| Q2 24 | 0.43× | 0.78× | ||
| Q1 24 | 0.51× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $269.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $267.4M | — |
| 自由现金流率自由现金流/营收 | 39.0% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 1.62× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $888.4M | — |
8季度趋势，按日历期对齐
经营现金流PTCRPRX
| Q4 25 | $269.7M | $827.1M | ||
| Q3 25 | $104.0M | $702.6M | ||
| Q2 25 | $243.9M | $364.0M | ||
| Q1 25 | $281.3M | $596.1M | ||
| Q4 24 | $238.4M | $742.5M | ||
| Q3 24 | $98.1M | $703.6M | ||
| Q2 24 | $213.8M | $658.2M | ||
| Q1 24 | $250.7M | $664.6M |
自由现金流PTCRPRX
| Q4 25 | $267.4M | — | ||
| Q3 25 | $100.5M | — | ||
| Q2 25 | $242.0M | — | ||
| Q1 25 | $278.5M | — | ||
| Q4 24 | $235.7M | — | ||
| Q3 24 | $93.6M | — | ||
| Q2 24 | $212.2M | — | ||
| Q1 24 | $247.1M | — |
自由现金流率PTCRPRX
| Q4 25 | 39.0% | — | ||
| Q3 25 | 11.2% | — | ||
| Q2 25 | 37.6% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 41.7% | — | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 40.9% | — | ||
| Q1 24 | 41.0% | — |
资本支出强度PTCRPRX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.6% | — |
现金转化率PTCRPRX
| Q4 25 | 1.62× | 3.86× | ||
| Q3 25 | 0.30× | 2.44× | ||
| Q2 25 | 1.73× | 12.06× | ||
| Q1 25 | 1.73× | 2.50× | ||
| Q4 24 | 2.90× | 3.57× | ||
| Q3 24 | 0.78× | 1.29× | ||
| Q2 24 | 3.10× | 6.45× | ||
| Q1 24 | 2.19× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTC
| Support And Cloud Services | $393.3M | 57% |
| License | $269.7M | 39% |
| Technology Service | $22.9M | 3% |
| Perpetual License | $5.6M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
